Evaluating the impact of the Patient Preference Assessment Tool on clinicians' recommendations for phase I oncology clinical trials.

Rachel S HianikTaofeek OwonikokoJeffrey SwitchenkoMargie D DixonWalid L ShaibRebecca D Pentz

Published in: Psycho-oncology (2021)

The PPAT was impactful in an academic setting, exceeding our 20% impact threshold. This tool helps achieve the important goal of incorporating patient preferences into shared decision-making about clinical trials.

Keyphrases

clinical trial
case report
palliative care
phase ii
randomized controlled trial
open label
phase iii